查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318821

肥胖藥物、手術和設備市場 - 2023-2030 年全球預測

Obesity Treatment Market by Drugs, Surgery & Devices - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

到2023年，全球減重藥物、手術和設備市場預計將達到171.4億美元，年複合成長率為10.22%，預計到2030年將達到339.3億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球減重藥物、手術和設備市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.肥胖治療藥物、手術和設備的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球肥胖藥物、手術和設備市場的阻礙因素和影響是什麼？

3.在預測期內，減重藥物、手術和設備在全球市場上投資的產品/細分市場/應用/領域有哪些？

4.全球肥胖治療藥物、手術和設備市場的競爭策略為何？

5.全球肥胖治療藥物、手術和設備市場的技術趨勢和法律規範是什麼？

6.全球減肥藥物、手術和設備主要供應商的市場佔有率是多少？

7. 哪些型態和策略性舉措被認為適合進入全球肥胖藥物、手術和設備市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 世界各地肥胖症的盛行率
      • 體重管理和健身意識不斷增強
      • 減重手術數量增加
    • 抑制因素
      • 產品召回和高額的處理成本
    • 機會
      • 減重手術設備的技術進步
      • 新型微創減重藥物、手術及手術器械的調查
    • 任務
      • 與治療藥物相關的風險、併發症和副作用
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 肥胖藥物、手術及器械市場 藥物

  • 食慾抑制劑
  • 組合藥物
  • 引起吸收不良和飽足感的藥物

第7章 依手術設備分類的肥胖藥物、手術和設備市場

  • 可調式胃束帶
  • 透過十二指腸開關實現膽胰分流
  • 內視鏡手術
  • Roux-en-Y胃繞道手術
  • 袖狀胃切除術

第8章 美洲肥胖藥物、手術與設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區肥胖藥物、手術和設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲肥胖藥物、手術和設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-EC2E133E32F6

The Global Obesity Treatment Market is forecasted to grow significantly, with a projected USD 17.14 billion in 2023 at a CAGR of 10.22% and expected to reach a staggering USD 33.93 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Obesity Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Obesity Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drugs, market is studied across Appetite Suppressants, Combination Drugs, and Malabsorption & Satiety Drugs. The Malabsorption & Satiety Drugs is projected to witness significant market share during forecast period.

Based on Surgery & Devices, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures, Roux-en-Y Gastric Bypass, and Sleeve Gastrectomy. The Roux-en-Y Gastric Bypass is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Obesity Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Obesity Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Obesity Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Obesity Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Obesity Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Obesity Treatment Market?

6. What is the market share of the leading vendors in the Global Obesity Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Obesity Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Obesity Treatment Market, by Drugs, 2022 vs 2030
  • 4.3. Obesity Treatment Market, by Surgery & Devices, 2022 vs 2030
  • 4.4. Obesity Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of obese population worldwide
      • 5.1.1.2. Growing awareness regarding weight management and fitness
      • 5.1.1.3. Growing number of bariatric surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and high cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in obesity surgery devices
      • 5.1.3.2. Research about new minimally invasive obesity treatment procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Associated risks, complications and side effects of treatment therapeutics
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Obesity Treatment Market, by Drugs

  • 6.1. Introduction
  • 6.2. Appetite Suppressants
  • 6.3. Combination Drugs
  • 6.4. Malabsorption & Satiety Drugs

7. Obesity Treatment Market, by Surgery & Devices

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion With Duodenal Switch
  • 7.4. Endoscopic Procedures
  • 7.5. Roux-en-Y Gastric Bypass
  • 7.6. Sleeve Gastrectomy

8. Americas Obesity Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Obesity Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. OBESITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. OBESITY TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2022 VS 2030 (%)
  • FIGURE 5. OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2022 VS 2030 (%)
  • FIGURE 6. OBESITY TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. OBESITY TREATMENT MARKET DYNAMICS
  • FIGURE 8. OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. OBESITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 5. OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. OBESITY TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. OBESITY TREATMENT MARKET SIZE, BY MALABSORPTION & SATIETY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 9. OBESITY TREATMENT MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. OBESITY TREATMENT MARKET SIZE, BY BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. OBESITY TREATMENT MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. OBESITY TREATMENT MARKET SIZE, BY ROUX-EN-Y GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. OBESITY TREATMENT MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. OBESITY TREATMENT MARKET LICENSE & PRICING